S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NUVB Panacea Acquisition Corp

2.55

0.01 (0.39%)

Jan 17 2025 - Closed

Delayed by 15 minutes

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Panacea Acquisition Charts.

Panacea Acquisition (NYSE:NUVB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Panacea Acquisition Charts.

Panacea Acquisition Corp News

Nuvation Bio to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 6 January 2025 (2 weeks ago) • Business Wire

Nuvation Bio Receives Approval from China’s National Medical Products Administration for Taletrectinib for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
Monday 6 January 2025 (2 weeks ago) • Business Wire

U.S. Food and Drug Administration Accepts for Priority Review Nuvation Bio’s New Drug Application for Taletrectinib for the Treatment of Advanced ROS1-positive Non-Small Cell Lung Cancer
Monday 23 December 2024 (4 weeks ago) • Business Wire

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration
Friday 20 December 2024 (4 weeks ago) • PR Newswire (US)

Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference
Tuesday 26 November 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Nuvation Bio to Present at the Jefferies London Healthcare Conference
Tuesday 12 November 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 6 November 2024 (2 months ago) • Edgar (US Regulatory)

Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update
Wednesday 6 November 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 10 October 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 9 October 2024 (3 months ago) • Edgar (US Regulatory)

More Panacea Acquisition Corp News Articles

TheGlobe com (PK)

MineralRite (PK)

RespireRx Pharmaceuticals (CE)

UAV Corpoation (PK)

GBT Technologies (PK)

Good Vibrations Shoes (PK)

Bioelectronics (PK)

Rennova Health (CE)

Saddle Ranch Media (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions